Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Blueprint Medicines Corp
Today
Create an eToro account to buy BPMC stock on a secure, user-friendly, multi-asset trading platform.
Buy Blueprint Medicines Corp
BPMC Price
Blueprint Medicines Corp BPMC
Buy BPMC

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
BPMC Price

Blueprint Medicines Corp BPMC

$96.53-1.09(-1.12%)(1D)

BPMC Stock Price Chart

5.92%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Blueprint Medicines Corp share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Blueprint Medicines Corp share price today is 96.53, reflecting a -1.12% change over the last 24 hours and 1.89% over the past week. The current market capitalization of BPMC is 6.2B with an average volume in the last three months of 652194.61. The stock has a P/E ratio of -46.31 and a dividend yield of 0%. With the stock’s beta sitting at 1.35
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$6.2B
Day’s Range
i
Shows the high and low prices of the day.
87.87 - 98.64
52W Range
i
Shows the high and low prices of the last year.
43.82 - 121.49
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
652194.61
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-46.31
Revenue
i
The total income generated by this company’s goods and services last year.
$434.41M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$96.53
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.11
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.35
What Is Blueprint Medicines Corp?
Blueprint Medicines Corp is an American pharmaceutical and medical manufacturing company based in Cambridge, Massachusetts. Established in 2008, the firm focuses on the identification of kinases that act as drivers of genomically defined cancers and hematologic disorders. Operating globally, the firm uses its research to develop precision therapies that aim to provide significant clinical responses in patients and greatly increase quality of life.

The firm’s products include AYVAKIT/AYVAKYT (avapritinib), which is used for the treatment of a rare hematologic disorder called systemic mastocytosis (SM), characterised by the production of excess mast cells leading to the accumulation of mast cells in the bone marrow and other organs. Blueprint also produces GAVRETO (pralsetinib), an oral therapy for patients with RET-positive metastatic non-small lung cancer and advanced thyroid cancer.

The company has a number of products in the pipeline at various clinical and pre-clinical phases, primarily focused on improving outcomes for patients living with genomically defined cancers, advanced cancers, and hematologic disorders. The firm worked in collaboration with Genentech, a member of the Roche Group, to develop and commercialise pralsetinib as a therapy for patients with RET-altered cancers. Blueprint Medicines Corp is listed on the NASDAQ, where it trades under the stock ticker BPMC.

Learn more about the performance of BPMC share prices on eToro.
Buy BPMC

How can I buy Blueprint Medicines Corp stocks?

To purchase Blueprint Medicines Corp:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Blueprint Medicines Corp (BPMC) page and place an order to buy Blueprint Medicines Corp.
Buy BPMC
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Blueprint Medicines Corp
Invest in Blueprint Medicines Corp
Today
Create an eToro account to buy BPMC stock on a secure, user-friendly, multi-asset trading platform.
Buy BPMC

FAQ

The current price of BPMC is 96.53.
The average price target for Blueprint Medicines Corp is 96.53. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Blueprint Medicines Corp based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Blueprint Medicines Corp is 6.2B
Select the "1D" or "1W" timeframe on the eToro chart and zoom out to see the historical price movements of Blueprint Medicines Corp. The price of Blueprint Medicines Corp has ranged between 43.82 and 121.49 over the last year.
To buy BPMC, visit the "Blueprint Medicines Corp (BPMC)" page. Once you have created an account and deposited funds, click the "Trade" button and decide how much Blueprint Medicines Corp you want to purchase. You can also place an order that will buy BPMC at a specific price in the future.
Daily Movers
Today's biggest gainers and losers.
Buy BPMC
Scroll to top